Skip to content
15% off your first order15% off your first order

PT-141 10 mg vial

Also known as Bremelanotide

Sexual wellness

Investigated for central melanocortin and arousal pathways.

$69.00CAD· $6.90/mg
1
  • Ships from Canada in 1–2 business days
  • Free shipping over $120
  • Place your order, then send the e-Transfer. We pack it as soon as it arrives.

For research use only. Not for human consumption.

Complete your setup

Needles and wipes are free. Water is $19.

Compare. Side by side, from the research.

About PT-141

PT-141 is studied for its role in the signaling pathways tied to desire and motivation. Research focuses on central melanocortin receptors rather than the vascular system.

How it works

Central Signaling
Studied for activity at melanocortin receptors within the central nervous system, associated with motivation and arousal circuits.
Non-Vascular Pathway
Research explores a mechanism upstream of vascular response, working through neural signaling rather than circulation.
Read the full research

What you need

  • Bacteriostatic Water
  • Needles
  • Alcohol Wipes
  • A protocol guide comes with every order

Shipping & payment

  • Packed and dispatched within 1–2 business days
  • Delivered across Canada in 2–5 business days, tracked
  • Temperature-controlled packaging where the product needs it
  • Free shipping on orders over $120
  • Prices in CAD · pay by Interac e-Transfer
Format
Lyophilised powder in a sealed vial
Strength
10 mg per vial
Storage
Refrigerate, away from light. Once reconstituted, keep refrigerated and use within the window on the insert.
Reconstitution
2 mL bacteriostatic water for this 10 mg vial (5 mg/mL)
Route in research
Subcutaneous
SKU
P41

Handling

  1. 1ReconstituteAdd bacteriostatic water down the side of the vial. Swirl, never shake. Agitation damages the peptide chain.
  2. 2StoreRefrigerate at 2–8°C once mixed. Reconstituted peptide is stable for the window given in your protocol guide.
  3. 3Measure with the calculator Use an insulin syringe at the units your protocol specifies. Rotate sites and log what you take.
Purity
High-performance liquid chromatography (HPLC), by an independent laboratory
Identity
Mass spectrometry, on the same batch
How often
Every batch
COA
The certificate of analysis is matched to the lot code printed on your vial
Evidence
Approved analog

Check your lot

Every vial carries a lot code. Enter it, or scan the QR on the label, to see its expiry and certificate of analysis.

Approved analogBremelanotide, the name under which PT-141 is also known, has received regulatory approval for hypoactive sexual desire disorder, and its safety profile has been reported across a clinical development program that included phase 3 trials.

What research examines

  • Hypoactive sexual desire disorder in women
  • Central melanocortin receptor signaling
  • Desire and motivation pathways
  • Neural mechanisms upstream of vascular response

Reported in studies

  • Safety profile evaluated across a clinical development program that included phase 3 randomized controlled trials
  • Specific adverse events are not summarized on this page; the published phase 3 safety analysis is the primary reference
  • Safety data for research contexts outside the approved indication are limited
Read the full research page· 5 cited studies

Published research protocols

1 mg, as needed, 30 minutes before activity

Research protocols have used 500–2,000 mcg per administration, as needed.

For research use only. These figures summarize published research protocols. They are not instructions or medical advice.

Measure with the calculator

CoreX AI

Ask about PT-141

Plain answers, from the basics to the studies.

Research information, not medical advice.

Often researched with PT-141

FAQ

Questions, answered

  • PT-141, also known as Bremelanotide, is a peptide studied for its role in signaling pathways tied to desire and motivation. Research focuses on central melanocortin receptors rather than on the vascular system. Bremelanotide has been the subject of multiple reviews and a clinical development program, and published literature describes its regulatory approval for hypoactive sexual desire disorder. CoreX supplies PT-141 for laboratory research use only.

  • Research describes PT-141 as an agonist at melanocortin receptors in the central nervous system. These receptors are associated with motivation and arousal circuits. Rather than acting directly on circulation, the peptide is studied for influence on neural signaling that sits upstream of vascular response. This central, non-vascular mechanism is the main feature distinguishing it in the research literature on sexual-health pathways.

  • The most extensively studied area is hypoactive sexual desire disorder in women, which is the subject of several reviews and a phase 3 clinical program. Published reviews cover its physiology, assessment context, and clinical development history, including its first regulatory approval in 2019. Earlier work, including a 2004 review under the PT-141 name, examined its development as an investigational compound acting through central melanocortin signaling.

  • The safety profile of Bremelanotide has been analyzed across its clinical development program, including phase 3 randomized controlled trials, and that analysis is the primary published reference for adverse events. Specific adverse event rates are not summarized here. Safety data outside the approved clinical indication, including in research settings with different protocols, are limited, and findings from the clinical program should not be assumed to apply to every context.

  • Research protocols have used 500 to 2,000 mcg per administration, on an as-needed basis, via the subcutaneous route. These figures describe amounts reported in research settings and are not a recommendation for any individual. Each CoreX order ships with a protocol guide for laboratory reference. Researchers should consult the primary literature for the specific study designs in which these amounts were used.

Vial

Senescent-cell research

FOXO4 10 mg

$219/ 10 mg